Variations in PSA doubling time in patients with prostate cancer on “watchful waiting”: Value of short-term PSADT determinations☆
To access this article, please choose from the options below
☆ Supported in part by the American Foundation for Urologic Disease and National Institutes of Health grant T32 82088 to A. J. Stephenson.
PII: S0090-4295(04)00337-1
doi:10.1016/j.urology.2004.03.020
© 2004 Elsevier Inc. All rights reserved.
